Cetuximab for Elderly Patients With mCRC

NCT01718808 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
24
Enrollment
OTHER
Sponsor class

Stopped FU for 3 years from randomization as initially planned is stopped as we do not expect any changes to the endpoints in the future after one year of FU.

Conditions

Interventions

Sponsor

Swiss Cancer Institute